Concepedia

Shenda Gu

SG

12

Publications

3K

Citations

12

H-Index

2010

Active since

Affiliations

Oregon Health & Science University(Current)

PDX Pharmaceuticals (United States)

Lawrence Berkeley National Laboratory

UCSF Helen Diller Family Comprehensive Cancer Center

Shenda Gu is an author at Oregon Health & Science University specializing in medicine, nanomedicine, and cancer research.

ORCID

Top concepts

Publications per year

2010–2019

12

Publications

12

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

Eric A. Collisson, Anguraj Sadanandam, Peter Olson et al. · Nature Medicine · 2011 · 1.9K citations · Full text

, , +7

A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma

Eric A. Collisson, Christy L. Trejo, Jillian M. Silva et al. · Cancer Discovery · 2012 · 316 citations · Full text

Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2<sup>+</sup> Breast Cancer

Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu et al. · Advanced Functional Materials · 2015 · 188 citations · Full text

The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer

Zhi Hu, Ge Huang, Anguraj Sadanandam et al. · Breast Cancer Research · 2010 · 137 citations · Full text

PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer

Moataz Reda, Worapol Ngamcherdtrakul, Shenda Gu et al. · Cancer Letters · 2019 · 69 citations · Full text

, , +8

Rows per page

1–5 of 12